These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24148851)

  • 41. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.
    Madhavan M; Waks JW; Friedman PA; Kramer DB; Buxton AE; Noseworthy PA; Mehta RA; Hodge DO; Higgins AY; Webster TL; Witt CM; Cha YM; Gersh BJ
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003283. PubMed ID: 26921377
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease.
    Hess PL; Hellkamp AS; Peterson ED; Sanders GD; Al-Khalidi HR; Curtis LH; Hammill BG; Pun PH; Curtis JP; Anstrom KJ; Hammill SC; Al-Khatib SM
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):793-9. PubMed ID: 25038119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implantable cardioverter-defibrillators: indications and unresolved issues.
    Kedia R; Saeed M
    Tex Heart Inst J; 2012; 39(3):335-41. PubMed ID: 22719141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical Outcomes of Single- versus Dual-Chamber Implantable Cardioverter Defibrillators: Lessons from the Israeli ICD Registry.
    Konstantino Y; Haim M; Boxer J; Goldenberg I; Feldman A; Michowitz Y; Glikson M; Suleiman M;
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):718-23. PubMed ID: 26852908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary Prevention of Sudden Cardiac Death Early Post-Myocardial Infarction: Root Cause Analysis for Implantable Cardioverter-Defibrillator Failure and Currently Available Options.
    Elayi CS; Charnigo RJ; Heron PM; Lee BK; Olgin JE
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28630173
    [No Abstract]   [Full Text] [Related]  

  • 46. Effectiveness of a comprehensive interactive eHealth intervention on patient-reported and clinical outcomes in patients with an implantable cardioverter defibrillator [ACQUIRE-ICD trial]: study protocol of a national Danish randomised controlled trial.
    Pedersen SS; Skovbakke SJ; Wiil UK; Schmidt T; dePont Christensen R; Brandt CJ; Sørensen J; Vinther M; Larroudé CE; Melchior TM; Riahi S; Smolderen KGE; Spertus JA; Johansen JB; Nielsen JC
    BMC Cardiovasc Disord; 2018 Jul; 18(1):136. PubMed ID: 29969990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.
    Forleo GB; Della Rocca DG; Papavasileiou LP; Panattoni G; Sergi D; Duro L; Mahfouz K; Magliano G; Santini L; Romeo F
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):779-84. PubMed ID: 21941203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
    Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
    Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry.
    Bogossian H; Frommeyer G; Hochadel M; Ince H; Spitzer SG; Eckardt L; Maier SKG; Kleemann T; Brachmann J; Stellbrink C; Gonska BD; Kääb S; Senges J; Lemke B
    Clin Res Cardiol; 2020 Jul; 109(7):911-917. PubMed ID: 31823040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized clinical trials.
    Romero J; Díaz JC; Grushko M; Quispe R; Briceno D; Avendano R; Golive A; Pina I; Natale A; Garcia MJ; Jorde UP; Di Biase L
    Europace; 2018 Sep; 20(FI2):f211-f216. PubMed ID: 29161424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A patient decision aid for antidepressant use in pregnancy: study protocol for a randomized controlled trial.
    Vigod S; Hussain-Shamsy N; Grigoriadis S; Howard LM; Metcalfe K; Oberlander TF; Schram C; Stewart DE; Taylor VH; Dennis CL
    Trials; 2016 Feb; 17(1):110. PubMed ID: 26923796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Remote monitoring of patients with implantable cardioverter-defibrillators: can results from large clinical trials be transposed to clinical practice?
    Morichau-Beauchant T; Boulé S; Guédon-Moreau L; Finat L; Botcherby EJ; Périer MC; Salleron J; Guibout C; Marquié C; Klug D; Kouakam C; Wissocque L; Brigadeau F; Lacroix D; Kacet S
    Arch Cardiovasc Dis; 2014 Dec; 107(12):664-71. PubMed ID: 25241223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Wearable cardioverter-defibrillators: A review of evidence and indications.
    Cheung CC; Olgin JE; Lee BK
    Trends Cardiovasc Med; 2021 Apr; 31(3):196-201. PubMed ID: 32205034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator.
    Adduci C; Palano F; Silvetti G; Cosentino P; Francia P
    High Blood Press Cardiovasc Prev; 2020 Aug; 27(4):291-297. PubMed ID: 32519207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive value of gamma-glutamyltransferase for ventricular arrhythmias and cardiovascular mortality in implantable cardioverter-defibrillator patients.
    Zhou Y; Zhao S; Chen K; Hua W; Zhang S
    BMC Cardiovasc Disord; 2019 May; 19(1):129. PubMed ID: 31146684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation?
    Randles DA; Hawkins NM; Shaw M; Patwala AY; Pettit SJ; Wright DJ
    Europace; 2014 Jul; 16(7):1015-21. PubMed ID: 24351884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary prevention of sudden cardiac death with an entirely subcutaneous defibrillator in a patient with a large right atrial thrombus.
    Kolb C; Lennerz C; Semmler V; Jilek C
    Clin Res Cardiol; 2013 Feb; 102(2):169-70. PubMed ID: 23052334
    [No Abstract]   [Full Text] [Related]  

  • 58. Will imaging assist in the selection of patients with heart failure for an ICD?
    Gerson MC; Abdallah M; Muth JN; Costea AI
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):101-10. PubMed ID: 20129539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Red cell distribution width predicts death and appropriate therapy in patients with implantable cardioverter defibrillator: A simple measurement with prognostic value in a variety of diseases, may help in better selection of patients who will benefit the most from this device.
    Dabbah S; Chertin L; Khateeb A; Rosenfeld I; Suleiman M; Halabi M
    Pacing Clin Electrophysiol; 2017 Dec; 40(12):1384-1388. PubMed ID: 29067703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure.
    Elming MB; Nielsen JC; Haarbo J; Videbæk L; Korup E; Signorovitch J; Olesen LL; Hildebrandt P; Steffensen FH; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Egstrup K; Videbæk R; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Thune JJ
    Circulation; 2017 Nov; 136(19):1772-1780. PubMed ID: 28877914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.